CIK 0001788028 · <br>Emerging growth company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842984849
- Phone
- 6505491400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-12 | EMSTER KURT VON Director | Grant or award | +30,250 | 30,250 | ||
| 2022-10-12 | Shizuru Judith Anne Director | Grant or award | +29,500 | 1,159,012 | ||
| 2022-10-12 | Mahal Jeetinder Singh See Remarks | Grant or award | +214,722 | 324,349 | ||
| 2022-10-12 | Nolet Chris Director | Grant or award | +32,500 | 32,500 | ||
| 2022-10-12 | Lis William Director | Grant or award | +29,500 | 69,986 | ||
| 2022-10-12 | French Anna Louise Director | Grant or award | +30,750 | 30,750 | ||
| 2022-06-27 | Lis William Director | Sale | −24,743 | $2.08 | $51K | 40,486 |
| 2022-06-24 | Lis William Director | Sale | −24,743 | $2.02 | $50K | 65,229 |
| 2022-04-07 | Mahal Jeetinder Singh See Remarks | Grant or award · Stock Option (right to buy) | +48,441 | 48,441 | ||
| 2022-03-21 | MARTELL RON President, CEO and Director | Grant or award · Stock Option (right to buy) | +1,704,328 | 1,704,328 | ||
| 2022-03-21 | Klein Lawrence Otto Director | Grant or award · Stock Option (right to buy) | +78,045 | 78,045 | ||
| 2022-03-21 | EMSTER KURT VON Director | Grant or award · Stock Option (right to buy) | +78,045 | 78,045 | ||
| 2022-03-21 | Heller Kevin N. See Remarks | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-21 | Shizuru Judith Anne Director | Grant or award · Stock Option (right to buy) | +78,045 | 78,045 | ||
| 2022-03-21 | Mahal Jeetinder Singh COO,CFO and CS | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-21 | Mahal Jeetinder Singh COO,CFO and CS | Grant or award · Stock Option (right to buy) | +87,272 | 87,272 | ||
| 2022-03-21 | Nolet Chris Director | Grant or award · Stock Option (right to buy) | +78,045 | 78,045 | ||
| 2022-03-21 | Lis William See Remarks | Grant or award | +89,972 | 89,972 | ||
| 2022-03-21 | Lis William See Remarks | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-03-21 | Lis William See Remarks | Grant or award · Stock Option (right to buy) | +89,972 | 89,972 |
Page 6 of 7 · 129 trades